Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Eperture is a private U.S. healthcare technology company focused on digital support tools for people living with dementia, cognitive decline, and related caregiving needs. Its flagship product, RememberStuff, is an interactive tablet-based caregiving and engagement platform designed for use by individuals, families, and senior care communities. The company appears to operate at the intersection of digital health, age-tech, and non-drug dementia support, with commercialization alongside grant-funded development work. Public materials also indicate Eperture has received U.S. federal SBIR/STTR and NIH-related support to advance caregiver-patient communication and daily living assistance technology. The business is not a therapeutics developer; instead, it provides technology-enabled care support for home and facility settings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Eperture.